Stanford Medcast Episode 32: Hot Topics Mini-Series: Screening for Prostate Cancer

This episode is part of the Stanford Medicine Prostate Cancer CME Series: Treatment Across the Prostate Cancer Continuum. The goal of the Prostate Cancer Series is to enhance the learners understanding of complex treatment options, the latest diagnostics, current guidelines for testing, types of tests available as well as discussions on other conditions that may cause an elevated PSA. Geared towards primary care clinicians, an in-depth discussion of the various types of prostate cancer and treatment options are provided in this episode.

To Claim Credit for listening to this episode:
1. Go to 'Begin' and complete the 'Attestation.'
2. Follow prompts to complete an evaluation.
3. Credit hours will be reflected on your transcript, or you may download your certificate.

1. Evaluate the current guidelines for prostate screening and determine risk factors that may impact screening decisions.
2. Develop skills/strategies to determine when to refer to urology specialists.
3. Counsel patients on prostate cancer treatment options.

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Credit Designation 
American Medical Association (AMA) 
Stanford Medicine designates this Enduring Material for a maximum of 0.75 AMA PRA Category 1 Credits^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Accessibility Statement
 Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require  accommodations, please contact the CME Conference Coordinator.

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: https://laneguides.stanford.edu/multicultural-health

References/Bibliography
1.National Cancer Institute at the National Institutes of Health. Prostate-Specific Antigen (PSA) Test. 24 Feb 2021. https://www.cancer.gov/types/prostate/psa-fact-sheet
2.Pavlovich, C. Johns Hopkins Medicine. Prostate Cancer: Age-Specific Screening Guidelines. https://www.hopkinsmedicine.org/health/conditions-and-diseases/prostate-cancer/prostate-cancer-age-specific-screening-guidelines
3.Hoffman RM, Gilliland FD, Eley JW, Harlan LC, Stephenson RA, Stanford JL, Albertson PC, Hamilton AS, Hunt WC, Potosky AL. Racial and Ethnic Differences in Advanced-Stage Prostate Cancer: the Prostate Cancer Outcomes Study. JNCI: Journal of the National Cancer Institute. Volume 93, Issue 5, 7 March 2001, Pages 388–395. https://doi.org/10.1093/jnci/93.5.388
4.Kasivisvanathan V, Rannikko AS, Borghi M, et al. MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis. N Engl J Med.10 May 2018. 378:1767-1777. DOI: 10.1056/NEJMoa1801993
5.Schröder FH, Hugosson J, Roobol MJ, et al. Screening and Prostate-Cancer Mortality in a Randomized European Study. N Engl J Med. 26 Mar 2009; 360:1320-1328. DOI: 10.1056/NEJMoa0810084
6.Carter HB, Albertsen PC, Barry MJ et al: Early detection of prostate cancer: AUA Guideline. J Urol 2013; 190: 419.
7.Castro E, Goh C, Olmos D, et al. Germline BRCA Mutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer. J Clin Oncol. 2013 May 10; 31(14): 1748–1757.
8.Huggins C, Hodges CV. Studies on prostatic cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. J Urol. 2002 Feb;167(2 Pt 2):948-51; discussion 952.
9.Prostate Cancer Foundation. Gleason Score and Grade Group. https://www.pcf.org/about-prostate-cancer/diagnosis-staging-prostate-cancer/gleason-score-isup-grade/

For activity related questions, please contact
     Email: [email protected]

For CME general questions, please contact 
     Email: [email protected]

Mitigation of Relevant Financial Relationships

Stanford Medicine adheres to the Standards for Integrity and Independence in Accredited Continuing Education.

There are no relevant financial relationships with ACCME-defined ineligible companies for anyone who was in control of the content of this activity. 

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Ruth Adewuya, MD
Managing Director
Stanford University

Course Director

Nothing to disclose

James Brooks, MD
Professor
Stanford University

Faculty

Nothing to disclose

Jennifer N John
Medcast Intern
Center for Continuing Medical Education

Planner

Independent Contractor (included contracted research)-Pandia Health (Relationship has ended)

This CME activity is supported by an educational grant from Astellas Pharma Global Development, Inc. and its collaborative partner, Pfizer, Inc.